FDA  Approves Elan's Non-Narcotic Painkiller Prialt
14679
Biotech company Elan Corp. reported Tuesday that the Food and Drug Administration approved its non-narcotic painkiller Prialt to treat chronic pain.
609109
FRIDAY, Sept. 14 (HealthDay News) -- The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
754376
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
149931
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in premarket trade Wednesday after the US Food and Drug Administration approved the companies&#39; multiple sclerosis drug Tysabri.
131106
Shares in Elan, Ireland&#39;s major pharmaceutical company, jumped nearly 3 percent Wednesday after American authorities approved a new drug engineered to help sufferers of multiple sclerosis.
611251
Eli Lilly and Co on Tuesday said U.S.  regulators approved once-daily use of two low-dose forms of its  Cialis anti-impotence drug, offering greater convenience for  men expecting frequent sexual activity.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
397854
Oct. 27, 2004 -- The US FDA has approved the first artificial disc for the treatment of severe low back pain, the device&#39;s manufacturer reports.
633623
The government approved on Tuesday a drug that offers a new way of fighting severe pain, an option for patients who no longer benefit from morphine and other traditional pain medications.
668214
WASHINGTON The Food and Drug Administration has approved a drug designed to better fight what&#39;s described as the leading cause of cancer-related deaths in America.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
510581
AstraZeneca Plc has won US approval to market its Nexium ulcer pill as a treatment that reduces the risk of ulcers developing in patients on non-steroidal anti-inflammatory drugs, it said on Monday.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.
556783
QLT Inc. QLT.TO QLTI.O said on  Wednesday it won U.S. regulatory approval for the six-month  formulation of its prostate cancer treatment, Eligard.
407814
Shares in Irish drug group Elan Corp. PLC are expected to be in demand today, as investors react to news that Antegren, its multiple sclerosis (MS) drug now known as Tysabri, was granted accelerated approval by the US FDA last night.
187991
Investors and insomniacs can rest easy: The Food &amp; Drug Administration approved Lunesta, Sepracor&#39;s (SEPR ) new drug for sleeplessness, on Dec. 15.
494398
The US Food and Drug Administration on Friday approved a new Purdue Pharma LP opioid-based drug that aims to provide &quot;around-the-clock&quot; relief to patients with moderate to severe pain.